Open Access
Table III
Demographic characteristic of studies.
| No | Author, Year | total Sample | Gender | Age | Type of Ossifying fibroma | Site of Predilection | Radiological Finding | Type of Surgery | Recurrence after surgery | Averange Reccurence Time | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
||||||||||||||
| Male | Female | <18 Years | >18 Years | Ossifying fibroma | Trabecular Ossifying fibroma | Psammomatoid Ossifying fibroma | Mandible | Maxilla | Paranasal Sinuses | Well-Defined | Moderate defined | Ill − Defined | Radical Surgery | Conservative Surgery | |||||
| 1 | Liu Y et al. (2010) [5] | 20 Patients | (9/20) 45% | (11/20) 55% | (7/20) 35% | (13/20) 65% | (20/20) 100% | N/A | N/A | (16/20) 80% | (4/20) 20% | N/A | (5/20) 25% | N/A | (1/20) 5% | (7/9) 77.8% | (1/7) 14.3% | N/A | |
| (2/9) 22.2% | (1/2) 50% | ||||||||||||||||||
| 2 | Suarez-Soto (2013) [6] | 19 Patients | (1/3) 33.3% | (2/3) 66.7% | (2/3) 66.7% | (1/3) 33.3% | (3/19) 15.8% | N/A | N/A | (1/3) 33.3% | (2/3) 66.7% | N/A | N/A | N/A | N/A | (2/3) 66.7% | 0% | N/A | |
| (1/3) 33.3% | 100% | ||||||||||||||||||
| 3 | Mohanty et al. (2014) [7] | 25 patients | (14/25) 56% | (11/25) 44% | (6/25) 24% | (19/25) 76% | (24/25) 96% | N/A | (1/25) 4% | (18/25) 72% | (7/25) 28% | N/A | (15/25) 60% | (2/25) 8% | (4/25) 16% | (4/25) 16% | 0% | N/A | |
| (21/25) 84% | 0% | ||||||||||||||||||
| 4 | Han et al. (2015) [8] | 15 Patients | (5/15) 33.3% | (10/15) 66.7% | (15/15) 100% | N/A | N/A | (10/15) 66.7% | (5/15) 33.3% | (9/15) 60% | (6/15) 40% | N/A | (13/15) 86.67% | N/A | (2/15) 13.33% | (6/15) 40% | 0% | 17.1 Months (6 Monyhs − 5 years) | |
| (9/15) 60% | (3/9) 33.3% | ||||||||||||||||||
| 5 | Kumar et al. (2015) [9] | 10 Patients | (6/10) 60% | (4/10) 40% | (4/10) 40% | (6/10) 60% | (1/10)10% OF | (4/10) 40% (JOF) | (7/10) 70% | (3/10) 30% | N/A | N/A | N/A | N/A | 100% | 0% | N/A | ||
| (2/10)20% COF | |||||||||||||||||||
| (3/10)30% POF | |||||||||||||||||||
| 6 | Titinchi et al. (2016) [10] | 61 Patients | (22/61) 36.1% | (39/61) 63.9% | (22/61) 39.3% | (39/61) 60.7% | (61/61) 100% | N/A | N/A | (41/61) 67.2% | (16/61) 26.22% | N/A | (57/61) 94% | N/A | N/A | (4/22) 18.2% | 0% | N/A | |
| (18/22) 81.8% | (1/8) 5.5% | ||||||||||||||||||
| 7 | Liu Y et al. (2017) [11] | 50 Patients | (34/50) 68% | (16/50) 32% | (50/50) 100% | N/A | (29/50) 58% | (12/50) 24% | (9/50) 18% | (27/50) 54% | (23/50) 46% | N/A | (44/50) 88% | N/A | (6/50) 22% | (35/50) 70% | (6/35) 17.1% | 3-52 Months | |
| (7/50) 14% | (6/7) 86% | 75% of cases relapse in 1 year | |||||||||||||||||
| 8 | Liu JJ et al. (2017) [12] | 13 Patients | (4/13) 31% | (9/13) 69% | (4/13) 30.8% | (9/13) 69.2% | (9/13) 69.2% | N/A | (4/13) 30.8% | N/A | (5/13) 38.5% | (8/13) 61.5% | N/A | N/A | N/A | (8/13) 69.2% | (2/8) 25% | N/A | |
| (3/13) 23.1% | (1/3) 33.3% | ||||||||||||||||||
| Total Precentage | 200 Patients | (95/213) 44.6% | (118/213) 55.4% | (110/213) 51.6% | (87/200) 40.8% | (152/213) 71.4% | (54/213) 25.4% JOF | (119/213) 55.9% | (61/200) 30.9% | (8/213) 3.6% | (134/213) 62.9% | (2/213) 0.9% | (26/200) 12.2% | (76/200) 35.7% | (61/213) 28.6% | Radical surgery: (9/76) 11.8% | |||
| (22/213) 10.3% | (19/213) 8.9% | Conservative surgery: (12/61) 19.7% | |||||||||||||||||
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.